The improvement of Cutaneous leishmaniasis treatment by Nanomedicine-based strategies | ||||
Translational Health Sciences | ||||
Volume 1, Issue 2, August 2025, Page 86-112 PDF (737.77 K) | ||||
Document Type: Review Article | ||||
DOI: 10.21608/ths.2025.413053.1014 | ||||
![]() | ||||
Author | ||||
Huda O. AbuBakr ![]() | ||||
Department of Biochemistry/Faculty of veterinary medicine/Egyptian Chinese University | ||||
Abstract | ||||
Nowadays, Nanomedicine strategies become the selective drug of choice that were modified and effectively applied in clinical settings for several diseases. Leishmania is a parasite that has zoonotic effect through animals and human. This neglected of leishmaniasis disease result in arise of new million cases per year. The most common two forms are cutaneous form; that cause skin sores ; and visceral form that affect internal organs. Accelerated wound healing, less scarring, prevention of parasite transmission and relapse are the goals of treatment for cutaneous leishmaniasis. Regretfully, none of the available medications were created effectiveness to this disease condition due to high toxicity ,low efficiency, resistant strains, adverse effects, high costs , and long treatments,.Nanomedicine devices with drug delivery is considered a promising tool to accelerate tissue regeneration to various diseases. While these delivery devices help in decreasing secondary bacterial infection through targeting antileishmanial effect . Thus, In this review ;we addressed nanomedicine based strategies to achieve scarless wound healing , low disease transmission , and reduce drug toxicity.. | ||||
Keywords | ||||
Nanomedicine; Leishmania; zoonotic; secondary infection; prevention | ||||
Statistics Article View: 9 PDF Download: 5 |
||||